217 related articles for article (PubMed ID: 21821501)
21. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M;
JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298
[TBL] [Abstract][Full Text] [Related]
22. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
23. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.
Parissis JT; Panou F; Farmakis D; Adamopoulos S; Filippatos G; Paraskevaidis I; Venetsanou K; Lekakis J; Kremastinos DT
Am J Cardiol; 2005 Aug; 96(3):423-6. PubMed ID: 16054474
[TBL] [Abstract][Full Text] [Related]
24. Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
Paraskevaidis IA; Ikonomidis I; Parissis J; Papadopoulos C; Stassinos V; Bistola V; Anastasiou-Nana M
Int J Cardiol; 2012 May; 157(1):31-7. PubMed ID: 21176979
[TBL] [Abstract][Full Text] [Related]
25. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
[TBL] [Abstract][Full Text] [Related]
26. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
[TBL] [Abstract][Full Text] [Related]
27. [Effect of levosimendan on B-type natriuretic peptide levels in patients with advanced heart failure: a meta-analysis].
Xu ZD; He WX; Zhao YF; Xia SX; He B; Yang T; Cao DX; Peng SL; Li J; Cao MH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2027-9. PubMed ID: 19861257
[TBL] [Abstract][Full Text] [Related]
28. Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
Büyüklü M; Kürüm AT; Tatlý E; Set T
Arq Bras Cardiol; 2012 Jul; 99(1):659-64. PubMed ID: 22735864
[TBL] [Abstract][Full Text] [Related]
29. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G
Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355
[TBL] [Abstract][Full Text] [Related]
30. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
[TBL] [Abstract][Full Text] [Related]
31. Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
Giamouzis G; Giannakoulas G; Tsarpalis K; Agha SA; Georgiopoulou V; Kalogeropoulos A; Karvounis H; Butler J
Int J Cardiol; 2008 Aug; 128(1):91-3; author reply 94-6. PubMed ID: 18495268
[No Abstract] [Full Text] [Related]
32. Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure.
Malfatto G; Della Rosa F; Rella V; Villani A; Branzi G; Blengino S; Giglio A; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):322-30. PubMed ID: 24699010
[TBL] [Abstract][Full Text] [Related]
33. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
Çavuşoğlu Y; Korkmaz Ş; Demirtaş S; Gencer E; Şaşmaz H; Mutlu F; Güneş H; Mert UK; Özdemir S; Kalaycı S; Yılmaz MB
Anatol J Cardiol; 2015 Aug; 15(8):611-7. PubMed ID: 26301344
[TBL] [Abstract][Full Text] [Related]
34. Preoperative levosimendan in heart failure patients undergoing noncardiac surgery.
Katsaragakis S; Kapralou A; Markogiannakis H; Kofinas G; Theodoraki EM; Larentzakis A; Menenakos E; Theodorou D
Neth J Med; 2008 Apr; 66(4):154-9. PubMed ID: 18424862
[TBL] [Abstract][Full Text] [Related]
35. Effects of levosimendan on quality of life and emotional stress in advanced heart failure patients.
Parissis JT; Papadopoulos C; Nikolaou M; Bistola V; Farmakis D; Paraskevaidis I; Filippatos G; Kremastinos D
Cardiovasc Drugs Ther; 2007 Aug; 21(4):263-8. PubMed ID: 17610056
[TBL] [Abstract][Full Text] [Related]
36. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
[TBL] [Abstract][Full Text] [Related]
37. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
[TBL] [Abstract][Full Text] [Related]
38. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
[TBL] [Abstract][Full Text] [Related]
39. Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan.
Qarawani D; Cohen A; Nahir M; Hasin Y
Int J Cardiol; 2013 Sep; 168(1):237-42. PubMed ID: 23063476
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]